J. Coburn

Keith C. Norris, J. Kopp, D. Sherrard, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Early deposition of aluminum in bone in diabetic patients on hemodialysis.

J. Kopp, D. Sherrard, J. Coburn, 1987, The New England journal of medicine.

Divalent Ion Metabolism

C. Kleeman, J. Coburn, D. Hartenbower, 1978 .

Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease.

S. Massry, P. Weidmann, M. Maxwell, 1973, The Journal of clinical endocrinology and metabolism.

Effect of MgCl2 infusion on urinary Ca and Na during reduction in their filtered loads.

S. Massry, C. Kleeman, J. Coburn, 1967, The American journal of physiology.

The acute effect of adrenal steroids on the interrelationship between the renal excretion of sodium, calcium, and magnesium.

S. Massry, C. Kleeman, J. Coburn, 1967, The Journal of laboratory and clinical medicine.

Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads.

S. Massry, C. Kleeman, J. Coburn, 1967, The American journal of physiology.

Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome

J. Coburn, M. Rubini, H. Goldstein, 1969 .

Parenteral nutrition: effect on bone and mineral homeostasis.

J. Coburn, G. Klein, 1991, Annual review of nutrition.

Metabolic bone disease associated with total parenteral nutrition.

J. Coburn, G. Klein, J. W. Coburn, 1984, Advances in nutritional research.

BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITION

A. Norman, D. Sherrard, J. Coburn, 1980, The Lancet.

Spontaneous Variations in Electrolyte Excretion in the Awake Dog 1 2

S. Massry, J. Coburn, R. Friedler, 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Control of serum phosphorus in uremia.

I. Salusky, J. Coburn, 1989, The New England journal of medicine.

Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.

A. Norman, J. Coburn, D. Hartenbower, 1974, The Western journal of medicine.

TURNOVER OF ENDOGENOUS PARATHYROID HORMONE IN UREMIC PATIENTS AND THOSE UNDERGOING HEMODIALYSIS

S. Massry, M. Peacock, C. Kleeman, 1972, Transactions - American Society for Artificial Internal Organs.

The influence of extracellular volume expansion on renal phosphate reabsorption in the dog.

S. Massry, C. Kleeman, J. Coburn, 1969, The Journal of clinical investigation.

1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.

S. Massry, A. Norman, D. Sherrard, 1974, Archives of internal medicine.

Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.

S. Massry, C. Kleeman, M. Maxwell, 1969, Archives of internal medicine.

Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy.

S. Massry, C. Kleeman, M. Maxwell, 1970, American Journal of Medicine.

Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia.

A. Arieff, S. Massry, C. Kleeman, 1974, Kidney international.

Microradiographic studies of bone in renal osteodystrophy.

J. Jowsey, S. Massry, C. Kleeman, 1969, Archives of Internal Medicine.

Renal Osteodystrophy and Maintenance Dialysis

J. Coburn, F. Llach, 1983 .

Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms.

S. Massry, J. Coburn, 1970, The Journal of clinical investigation.

Effect of chronic metabolic acidosis on vitamin D metabolism in humans.

E. Slatopolsky, K. Kurokawa, R. Horst, 1983, Kidney international.

Intermittent oral 1 a-hydroxyvitamin D 2 is e ff ective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients

R. Chesney, J. Coburn, J. Frazão, 1998 .

1α-Hydroxy-vitamin D2: a new look at an ‘old’ compound

R. Mazess, J. Coburn, J. Knutson, 1996 .

Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.

R. G. Wong, A. Norman, J. Coburn, 1972, The Journal of clinical investigation.

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

H. Malluche, W. Goodman, J. Coburn, 2008, Clinical nephrology.

Renal action of cholera toxin: I. Effects on urinary excretion of electrolytes and cyclic AMP.

S. Massry, K. Kurokawa, J. Coburn, 1975, Kidney international.

Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus.

A. Norman, A. Brickman, J. Coburn, 1977, The American journal of clinical nutrition.

Protein losses during peritoneal dialysis.

J. Kopple, M. Blumenkrantz, J. Coburn, 1981, Kidney international.

Vitamin D: Normal Physiology and Vitamin D Therapeutics in Normal Nutrition and Various Disease States

J. Coburn, J. Frazão, 2002 .

Interaction of somatostatin with PTH and AVP: renal effects.

C. Kleeman, J. Coburn, N. Brautbar, 1979, The American journal of physiology.

CHAPTER 40 – Renal Bone Diseases: Clinical Features, Diagnosis, and Management

I. Salusky, J. Coburn, 2001 .

26 – Renal Bone Diseases

J. Coburn, 1999 .

Infantile vitamin D-resistant rickets associated with total parenteral nutrition.

R. A. Cannon, A. Norman, H. Kangarloo, 1982, American journal of diseases of children.

Reduced Serum Levels of Iα, 25-Dihydroxyvitamin D During Long-term Total Parenteral Nutrition

A. Norman, E. Slatopolsky, R. Horst, 1981 .

Interactions between Vitamin D and the Kidney

S. Massry, J. Coburn, R. Saltzman, 1976 .

1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure.

S. Massry, A. Norman, A. Brickman, 1974, Annals of internal medicine.

EARLY RENAL FAILUREl

W. Goodman, J. Coburn, 1992 .

Bone disease in burn patients

D. Herndon, T. Rutan, D. Sherrard, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.

A. Brickman, J. Coburn, 1978, Advances in experimental medicine and biology.

Calcifediol in Chronic Renal Insufficiency

A. Norman, J. Coburn, 1976 .

NephrologyDialysis Transplantation la-Hydroxy-vitamin D2: a new look at an 'old' compound

R. Mazess, J. Coburn, J. Knutson, 2022 .

Calciferol metabolism and intestinal calcium transport in the chick with reduced renal function.

A. Norman, J. Coburn, D. Hartenbower, 1974, The Journal of laboratory and clinical medicine.

Impaired calcium absorption in uremic man: evidence for defective absorption in the proximal small intestine

S. Massry, A. Norman, A. Brickman, 1974 .

An update on vitamin D as related to nephrology practice: 2003.

J. Coburn, 2003, Kidney international. Supplement.

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism

Keith C. Norris, R. Mazess, R. Chesney, 2000 .

Plasma aluminum levels in pediatric dialysis patients: comparison of hemodialysis and continuous ambulatory peritoneal dialysis.

D. Milliner, J. Coburn, E. Lieberman, 1987, Mayo Clinic proceedings.

Hypercalcemia in reticulum cell sarcoma without hyperparathyroidism of skeletal metastases.

A. Brickman, F. Singer, J. Coburn, 1973, Annals of internal medicine.

Severe hypokalaemic metabolic alkalosis following ingestion of gaviscon®

P. Dargan, J. Coburn, I. Gawarammana, 2007, Clinical toxicology.

Magnesium, the mimic/antagonist to calcium.

J. Coburn, B. Levine, 1984, The New England journal of medicine.

Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.

S. Massry, A. Norman, A. Brickman, 1973, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry.

A. Fenves, J. Coburn, J. Boelaert, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acute interstitial nephritis due to methicillin.

R. Glassock, A. Bayer, M. Blumenkrantz, 1978, The American journal of medicine.

Use of calcium carbonate as a phosphate binder in dialysis patients.

D. Sherrard, J. Coburn, J. Kraut, 1986, Mineral and electrolyte metabolism.

Renal bicarbonate wasting during phosphate depletion. A possible cause of altered acid-base homeostasis in hyperparathyroidism.

L. W. Gold, S. Massry, J. Coburn, 1973, The Journal of clinical investigation.

Thiazide-lnduced Rise in Serum Calcium and Magnesium in Patients on Maintenance Hemodialysis

S. Massry, J. Coburn, J. Shinaberger, 1970 .

Beta2-microglobulin deposition in bone in chronic renal failure

D. Sherrard, J. Coburn, D. Andress, 1991 .

Amyloid syndromes associated with hemodialysis.

J. Coburn, K. Kleinman, 1989, Kidney international.

Clinical Pharmacology and Application of the Active Forms of Vitamin D

A. Brickman, J. Coburn, 1979 .

Pharmacokinetics and biologic effects of calcitriol in normal humans.

F. Singer, J. Coburn, G. Bryce, 1985, The Journal of laboratory and clinical medicine.

Calcium-sensing receptor and calcimimetic agents.

W. Goodman, J. Coburn, L. Elangovan, 1999, Kidney international. Supplement.

Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.

A. Norman, A. Brickman, J. Coburn, 1978, Metabolism: clinical and experimental.

Renal failure following methylglucamine diatrizoate (renografin) aortography: report of a case with unilateral renal artery stenosis.

J. Coburn, F. R. Stark, 1966, The Journal of urology.

Candida peritonitis. Report of 22 cases and review of the English literature.

A. Bayer, M. Blumenkrantz, J. Coburn, 1976, The American journal of medicine.

Biological activity of 24,25-dihydroxycholecalciferol in chicks and rats.

A. Norman, J. Coburn, H. Henry, 1976, The Journal of nutrition.

Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.

S. Massry, A. Norman, A. Brickman, 1976, The Journal of clinical investigation.

The effect of calcium infusion on renal handling of magnesium with normal and reduced glomerular filtration rate.

S. Massry, C. Kleeman, J. Coburn, 1970, Nephron.

The use of 1,25-dihydroxyvitamin D3 in early renal failure.

W. Goodman, J. Coburn, 1992, Annual review of medicine.

Calcimimetic agents and the calcium-sensing receptor.

J. Coburn, H. Maung, 2000, Current opinion in nephrology and hypertension.

Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.

J. Coburn, M. Rubini, H. Goldstein, 1969, The New England journal of medicine.

Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group.

R. Chesney, J. Coburn, J. Frazão, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.

Keith C. Norris, R. Mazess, R. Chesney, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Intestinal absorption of calcium and the effect of renal insufficiency.

S. Massry, J. Coburn, D. Hartenbower, 1973, Kidney international.

Parenteral aluminum administration in the dog: I. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone.

D. Henry, W. Goodman, E. Slatopolsky, 1984, Kidney international.

Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism.

D. Henry, W. Goodman, R. Horst, 1984, Kidney international.

Renal Osteodystrophy in Children Undergoing Continuous Ambulatory Peritoneal Dialysis

H. Kangarloo, J. Kopple, I. Salusky, 1984, Pediatric Research.

Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

A. Norman, A. Brickman, J. Coburn, 1972, The New England journal of medicine.

Calcitriol in the Management of Renal Osteodystrophy

J. Coburn, J. Frazão, 1996 .

Renal osteodystrophy in end-stage renal failure.

J. Coburn, D. Nortman, 1978, Postgraduate medicine.

Advances in vitamin D metabolism as they pertain to chronic renal disease.

A. Brickman, J. Coburn, D. Hartenbower, 1976, The American journal of clinical nutrition.

Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.

S. Massry, A. Norman, A. Brickman, 1974, The American journal of medicine.

A controlled evaluation of clinical and metabolic effects of dialysate calcium levels during regular hemodialysis.

S. Massry, J. Coburn, J. Jowsey, 1971, Transactions - American Society for Artificial Internal Organs.

Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient?

Keith C. Norris, C. Kleeman, J. Coburn, 1987, Mineral and electrolyte metabolism.

Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3.

S. Massry, A. Norman, J. Garty, 1976, Kidney international.

The interrelationship between sodium, calcium, and magnesium excretion in advanced renal failure.

S. Massry, C. Kleeman, M. Popovtzer, 1969, The Journal of laboratory and clinical medicine.

Renal osteodystrophy: some new questions on an old disorder.

W. Goodman, J. Coburn, D. B. Lee, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prostaglandins: effect on plasma calcium concentration.

F. Singer, J. Coburn, O. M. Beliel, 1973, Prostaglandins.

IgG antibodies against bovine serum albumin in humans--their prevalence and response to exposure to bovine serum albumin.

J. Coburn, D. Kuter, Junzhi Li, 2005, Journal of immunological methods.

The acute effects of 1,25-dihydroxycholecalciferol on serum immunoreactive parathyroid hormone in the dog.

A. Norman, J. Coburn, H. Henry, 1979, Endocrinology.

Effect of metabolic acidosis on phosphate transport by the renal brush-border membrane.

K. Kurokawa, J. Coburn, J. Kraut, 1983, Biochimica et biophysica acta.

Osteomalacia and bone disease arising from aluminum.

Keith C. Norris, J. Coburn, H. G. Nebeker, 1986, Seminars in nephrology.

Aluminum and renal osteodystrophy.

J. Coburn, H. G. Nebeker, 1986, Annual review of medicine.

Role of Aluminum Accumulation in Renal Osteodystrophy

S. Ott, D. Milliner, J. Coburn, 1984 .

Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia.

A. Norman, D. Sherrard, A. Brickman, 1983, The American journal of medicine.

Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.

A. Norman, D. Sherrard, A. Brickman, 1981, Annals of internal medicine.

The role of vitamin D in idiopathic hypercalciuria.

S. Brosman, J. Coburn, S. Das, 1979, The Journal of urology.

Absorption and action of insulin added to peritoneal dialysate in dogs.

S. Levin, M. Blumenkrantz, J. Coburn, 1979, Nephron.

Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure.

W. Suki, S. Massry, K. Parsa, 1976, Archives of internal medicine.

Metabolic balance study of plasmapheresis in a case of Waldenstrom's macroglobulinemia.

W. S. Adams, J. Coburn, W. Skoog, 1962, Blood.

The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.

S. Massry, C. Kleeman, J. Coburn, 1971, California medicine.

7 – Renal osteodystrophy

J. Coburn, B. A. Liebross, Jack W. Coburn, 1982 .

24,25-dihydroxy-cholecalciferol, a vitamin D sterol with qualitatively unique effects in uremic man

A. Brickman, F. Singer, J. Coburn, 1979 .

Studies on calciferol metabolism. VII. The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution.

A. Norman, J. Coburn, A. Spielvogel, 1973, The Journal of clinical endocrinology and metabolism.

Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.

J. Kopp, D. Sherrard, J. Coburn, 1986, The Journal of clinical endocrinology and metabolism.

Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis.

D. Sherrard, I. Salusky, R. Fine, 1984, The Journal of pediatrics.

Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism.

J. H. Kaye, S. Massry, F. Singer, 1975, The Journal of clinical endocrinology and metabolism.

Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.

D. Sherrard, J. Coburn, D. Andress, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Iliac crest bone biopsy for diagnosis of aluminum toxicity and a guide to the use of deferoxamine.

Keith C. Norris, W. Goodman, J. Coburn, 1986, Seminars in nephrology.

Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.

S. Ott, D. Milliner, D. Sherrard, 1986, Kidney international. Supplement.

Evolution of Renal Osteodystrophy and the Effect of High-Dose Calcitriol in Children Undergoing CAPD

H. Kangarloo, I. Salusky, R. Fine, 1985 .

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.

Keith C. Norris, R. Mazess, R. Chesney, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Histological quantitation of aluminum in iliac bone from patients with renal failure.

S. Ott, D. Sherrard, J. Coburn, 1982, The Journal of laboratory and clinical medicine.

Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.

D. Sherrard, A. Brickman, F. Singer, 1980, Contributions to nephrology.

Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy.

J. Coburn, 1990, Kidney international. Supplement.

Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels.

Keith C. Norris, D. Sherrard, E. Slatopolsky, 1987, Transactions of the Association of American Physicians.

Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.

S. Ott, D. Milliner, D. Sherrard, 1984, Annals of internal medicine.

Controlled comparison of 20-g and 40-g protein diets in the treatment of chronic uremia.

J. Kopple, J. Coburn, M. Rubini, 1968, The American journal of clinical nutrition.

Aluminum-Containing Phosphate Binding Agents and Plasma Aluminum Levels in Children Undergoing CAPD: Preliminary Results with the Use of Calcium Carbonate

I. Salusky, R. Fine, L. Paunier, 1985 .

Risk factors for aluminum toxicity and its prevention

W. Goodman, J. Coburn, 1990 .

Changes in bone histology after treatment with desferrioxamine.

S. Ott, D. Milliner, D. Sherrard, 1986, Kidney international. Supplement.

Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.

A. Norman, D. Sherrard, A. Brickman, 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Bone histologic response to deferoxamine in aluminum-related bone disease.

S. Ott, D. Sherrard, E. Slatopolsky, 1987, Kidney international.

Prevention of phosphate retention and hyperphosphatemia in uremia.

J. Coburn, G. Hercz, 1987, Kidney international. Supplement.

Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.

D. Sherrard, J. Coburn, D. Andress, 1987, The Journal of clinical endocrinology and metabolism.

Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome.

Keith C. Norris, D. Milliner, D. Sherrard, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Toxic effects of aluminum in end-stage renal disease: discussion of a case.

Keith C. Norris, D. Sherrard, E. Slatopolsky, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia.

D. Sherrard, F. Singer, K. Kurokawa, 1983, Kidney international.

Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure.

S. Massry, P. Weidmann, C. Kleeman, 1972, Annals of internal medicine.

Evaluating modified protein diets for uremia.

J. Kopple, J. Coburn, M. Rubini, 1969, Journal of the American Dietetic Association.

Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamine.

Keith C. Norris, I. Salusky, R. Fine, 1986, Kidney international.

Calcific periarthritis and hemodialysis.

J. Coburn, R. Bluestone, K. Mirahmadi, 1973, JAMA.

Evidence for suppression of parathyroid gland activity by hypermagnesemia.

S. Massry, C. Kleeman, J. Coburn, 1970, The Journal of clinical investigation.

The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.

S. Ott, D. Sherrard, J. Coburn, 1982, The New England journal of medicine.

Hypocalcemia in magnesium-depleted dogs: evidence for reduced responsiveness to parathyroid hormone and relative failure of parathyroid gland function.

S. Massry, C. Kleeman, J. Coburn, 1974, Metabolism: clinical and experimental.

Studies on mechanisms of hypocalcemia of magnesium depletion.

S. Massry, A. Brickman, J. Coburn, 1973, The Journal of clinical investigation.

Intestinal Absorption of Calcium: Its Assessment, Normal Physiology, and Alterations in Various Disease States

J. Coburn, B. Levine, M. Walling, 1982 .

Study of intestinal absorption of calcium in patients with renal failure.

S. Massry, A. Brickman, J. Coburn, 1973, Kidney international.

Renal handling of magnesium in the dog.

S. Massry, C. Kleeman, J. Coburn, 1969, The American journal of physiology.

Abnormalities of the musculoskeletal system in hemodialysis patients.

S. Massry, J. Coburn, J. Klinenberg, 1975, Seminars in arthritis and rheumatism.

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.

B. Culleton, J. Coburn, S. Roger, 2005, Journal of the American Society of Nephrology : JASN.

The effect of calcemic disorders and uremia on the mineral content of skin.

S. Massry, C. Kleeman, J. Coburn, 1971, Israel journal of medical sciences.

The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.

W. Goodman, J. Coburn, R. Cohen, 2002, Journal of the American Society of Nephrology : JASN.

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.

W. Liu, W. Goodman, J. Coburn, 2000, Kidney international.

Disorders of Magnesium Homeostasis and Magnesium in Therapy

J. Coburn, B. Levine, 1998 .

Destructive Spondyloarthropathy of the Cervical Spine in Patients With Chronic Renal Failure

R. Delamarter, E. L. Freedman, J. Coburn, 1997, Spine.

Faraday-rotation studies of CaF2:Eu

D. E. Brodie, R. R. Haering, J. Coburn, 1970 .

Effect of vitamin D sterols and dietary magnesium on calcium and phosphorous homeostasis.

J. Coburn, B. Levine, M. Walling, 1981, The American journal of physiology.

Scalene lymph node involvement in primary and disseminated coccidioidomycosis. Evidence of extrapulmonary spread in primary infection.

J. Coburn, 1962, Annals of internal medicine.

Registry on mucormycosis in dialysis patients.

A. Fenves, J. Coburn, J. Boelaert, 1989, The Journal of infectious diseases.

Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients.

Keith C. Norris, J. Adams, G. Segre, 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis.

Keith C. Norris, W. Goodman, I. Salusky, 1989, Annals of Internal Medicine.

Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.

S. Ott, D. Sherrard, J. Coburn, 1983, Annals of Internal Medicine.

Bone aluminum and histomorphometric features of renal osteodystrophy.

S. Ott, D. Sherrard, A. Brickman, 1982, The Journal of clinical endocrinology and metabolism.

The effect of chronic metabolic acidosis on the end organ responsiveness to parathyroid hormone in man.

K. Kurokawa, J. Coburn, J. Kraut, 1983, The Journal of clinical endocrinology and metabolism.

Effect of metabolic acidosis in intestinal absorption of calcium and phosphorus.

M. Haussler, K. Kurokawa, J. Coburn, 1980, The American journal of physiology.

Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis.

A. M. Horowitz, A. Arieff, R. Cutler, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The problem and unanswered questions. Renal osteodystrophy, soft tissue calcification, and distrubed divalent ion metabolism in chronic renal failure.

S. Massry, C. Kleeman, M. Popovtzer, 1969, Archives of internal medicine.

Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content.

S. Ott, D. Sherrard, E. Slatopolsky, 1988, The American journal of clinical nutrition.

Clearance of aluminum by hemodialysis: effect of desferrioxamine.

A. Nissenson, D. Milliner, J. Coburn, 1986, Kidney international. Supplement.

Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide.

W. Goodman, I. Salusky, J. Coburn, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of 1α,25-,24R,25-, and 1α,24R,25-hydroxylated metabolites of vitamin D3on calcium and phosphate absorption by duodenum from intact and nephrectomized rats

A. Norman, J. Coburn, M. Walling, 1977 .

Early renal adaptation to dietary phosphorus restriction.

K. Kurokawa, J. Coburn, B. Levine, 1984, Advances in experimental medicine and biology.

Renal artery embolism: clinical features and long-term follow-up of 17 cases.

J. Coburn, J. Kaufman, S. F. Johnson, 1978, Annals of internal medicine.

The scintillation camera in embolic acute renal failure.

J. Coburn, E. Weiss, M. Winston, 1970, The Journal of urology.

Intestinal and parathyroid calcium-binding proteins in the dog. Comparison of biochemical properties and responses to vitamin D.

J. Coburn, S. Oldham, S. Mitnick, 1980, The Journal of biological chemistry.

Influence of dietary magnesium in experimental phosphate depletion: bone and soft tissue mineral changes.

C. Kleeman, J. Coburn, N. Brautbar, 1979, The American journal of physiology.

Aluminum as a factor in the bone disease of long-term parenteral nutrition.

S. Ott, D. Sherrard, J. Coburn, 1982, Transactions of the Association of American Physicians.

Role of growth hormone in experimental phosphorus deprivation in the rat

C. Kleeman, R. Grindeland, J. Coburn, 2006, Calcified Tissue International.

Interactions between vitamin D deficiency and phosphorus depletion in the rat.

J. Coburn, N. Brautbar, M. Walling, 1979, The Journal of clinical investigation.

The biochemical indices of experimental phosphorus depletion (PD): a re-examination of their physiological implications.

C. Kleeman, J. Coburn, N. Brautbar, 1978, Advances in experimental medicine and biology.

Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.

Keith C. Norris, J. Coburn, J W Coburn, 1986, Seminars in nephrology.

Relationship between urinary calcium and calcium intake during calcitriol administration.

F. Singer, J. Coburn, G. Bryce, 1986, Kidney international.

Pathophysiology of calcium, phosphorus, and magnesium

J. Coburn, C. Anast, F. Bronner, 1981 .

Hepatic aluminum accumulation in children on total parenteral nutrition.

J. Coburn, M. Ament, A. Alfrey, 1984, Journal of pediatric gastroenterology and nutrition.

Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis.

J. Kopple, M. Blumenkrantz, J. Moran, 1982, Kidney international.

The disappearance of intractable pruritus after parathyroidectomy in uremic patients with secondary hyperparathyroidism.

S. Massry, C. Kleeman, M. Maxwell, 1968, Transactions of the Association of American Physicians.

Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions.

D. Milliner, J. Coburn, J. Shinaberger, 1985, The New England journal of medicine.

Hypernatremic, hyperosmolar coma complicating chronic peritoneal dialysis.

A. Arieff, M. Blumenkrantz, J. Coburn, 1974, Proceedings of the Clinical Dialysis and Transplant Forum.

Effects of vitamin D and diet magnesium on magnesium metabolism.

J. Coburn, N. Brautbar, D. B. Lee, 1980, The American journal of physiology.

The hormonal and non-hormonal control of renal excretion of calcium and magnesium.

S. Massry, J. Coburn, 1973, Nephron.

Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease.

J. Coburn, J. Hiss, J. Dowling, 1963, The American journal of medicine.

Renal concentrating defect in canine radiation nephritis.

C. Kleeman, J. Coburn, M. Rubini, 1966, The Journal of laboratory and clinical medicine.

Renal adaptation to phosphorus deprivation: Characterization of early events

J. Coburn, B. Levine, K. Pasiecznik, 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Surgical management of secondary hyperparathyroidism.

J. Coburn, E. Passaro, H. E. Gordon, 1972, Archives of surgery.

Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.

J. Coburn, 1993, Kidney international. Supplement.

Bone disease in uremia.

J. Coburn, 1983, Henry Ford Hospital medical journal.

Postinfectious glomerulonephritis in a renal allograft associated with a mycotic aneurysm of a coronary artery.

G. Feld, J. Coburn, K. Kurokawa, 1984, The American journal of medicine.

Nutritional management of the adult patient undergoing peritoneal dialysis.

J. Kopple, M. Blumenkrantz, J. Coburn, 1978, Journal of the American Dietetic Association.

Calcium infusion test in renal failure.

S. Massry, C. Kleeman, M. Popovtzer, 1970, Nephron.

Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.

J. Coburn, J. Frazão, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

"High-dose" calcitriol for control of renal osteodystrophy in children on CAPD.

W. Goodman, E. Slatopolsky, H. Kangarloo, 1987, Kidney international.

Postinfectious glomerulonephritis in a renal allograft associated with a mycotic aneurysm of a coronary artery

G. Feld, J. Coburn, K. Kurokawa, 1984 .

Applications of the Redy sorbent system to hemodialysis and peritoneal dialysis.

M. Maxwell, M. Blumenkrantz, J. Moran, 2008, Artificial organs.

Development of a sorbent peritoneal dialysate regeneration system--a progress report.

M. Maxwell, M. Blumenkrantz, J. Coburn, 1978, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis.

J. Kopple, M. Blumenkrantz, J. Moran, 1982, The American journal of clinical nutrition.

Recurrent glomerulonephritis due to anti-glomerular basement membrane-antibodies in two successive allografts.

R. Glassock, J. Coburn, J. Shinaberger, 1973, Clinical nephrology.

Relationship between the kidney and parathyroid hormone.

S. Massry, F. Singer, K. Kurokawa, 1975, Nephron.

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

G. Chertow, S. Moe, J. Cunningham, 2005, Kidney international.

Biological effects of aluminum on normal dogs: studies on the isolated perfused bone.

S. Teitelbaum, E. Slatopolsky, J. Coburn, 1987, Endocrinology.

A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D.

A. Norman, D. Sherrard, A. Brickman, 1980, Contributions to nephrology.

Beta 2-microglobulin deposition in bone in chronic renal failure.

S. Onishi, D. Sherrard, J. Coburn, 1991, Kidney international.

The effects of aluminum loading on the renal response to parathyroid hormone in the vitamin D-replete rat.

A. Norman, M. Jongen, M. Vaccaro, 1986, Biochemical medicine and metabolic biology.

Medical treatment in primary and secondary hyperparathyroidism.

S. Massry, A. Brickman, J. Coburn, 1972, Seminars in drug treatment.

Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis.

I. Salusky, R. Fine, J. Coburn, 1986, The Journal of pediatrics.

30 Calcium and Phosphorus Metabolism and Bone Disease in Uremia

S. Massry, C. Kleeman, M. Popovtzer, 1970, Clinical orthopaedics and related research.

Oral and parenteral calcitriol for the management of end-stage renal disease.

Keith C. Norris, W. Goodman, I. Salusky, 1991, Contributions to Nephrology.

Calcium and inorganic phosphate transport in rat colon: dissociated response to 1,25-dihydroxyvitamin D3.

J. Coburn, U. Gafter, D. B. Lee, 1980, The Journal of clinical investigation.

The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. I.

S. Massry, C. Kleeman, J. Coburn, 1971, California medicine.

Acute renal failure in diabetic patients after intravenous infusion pyelography.

J. H. Kaye, J. Coburn, R. Goldman, 1973, Clinical nephrology.

Comparison of model and experiment for Ar, Ar/O2 and Ar/O2/Cl2 inductively coupled plasmas

David B. Graves, Cheng-Che Hsu, D. Graves, 2006 .

Gut absorption of calcium: interactions between phosphate and vitamin D.

J. Coburn, N. Brautbar, M. Walling, 1980, Advances in experimental medicine and biology.

Effect of phosphorus depletion on intestinal calcium and phosphorus absorption.

C. Kleeman, J. Coburn, N. Brautbar, 1979, The American journal of physiology.

On the mechanism and nature of the defect in intestinal absorption of calcium in uremia.

S. Massry, A. Norman, A. Brickman, 1975, Kidney international. Supplement.

Intestinal and metabolic effect of 1,25-dihydroxyvitamin D3 in normal adult rat.

J. Coburn, A. Hodsman, U. Gafter, 1981, The American journal of physiology.

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

W. Goodman, E. Slatopolsky, I. Salusky, 1988, Kidney international.

Mechanism of the Antidiuretic Effect of ß-Adrenergic Stimulation in Man

C. Kleeman, J. Coburn, J. Levi, 1976 .

Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances.

S. Massry, C. Kleeman, J. Coburn, 1968, The American journal of physiology.

End-stage renal failure.

J. Coburn, 1978, Postgraduate medicine.

Early renal brush border membrane adaptation to dietary phosphorus.

K. Kurokawa, J. Coburn, A. Hodsman, 1984, Mineral and electrolyte metabolism.

Effect of potassium depletion on response to acute heat exposure in unacclimatized man.

F. N. Craig, R. Reba, J. Coburn, 1966, American Journal of Physiology.

Rapid appearance of hypercalcemia with initiation of hemodialysis.

S. Massry, J. Coburn, J. Depalma, 1969, JAMA.

Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis.

S. Massry, J. Coburn, J. Shinaberger, 1970, Annals of internal medicine.

Prevention of metabolic bone disease in the pre-end-stage renal disease setting.

J. Coburn, L. Elangovan, Jack W. Coburn, 1998, Journal of the American Society of Nephrology : JASN.

Effect of acute and long-standing hypocalcemia on blood pressure and plasma renin activity in man.

S. Massry, P. Weidmann, M. Maxwell, 1974, The Journal of clinical endocrinology and metabolism.

Isosorbide: effects on renal function, renal clearance and tubular handling and volume of distribution in dogs.

R. Reba, K. Barry, J. Coburn, 1967, Journal of Pharmacology and Experimental Therapeutics.

Protein nutrition in uremia: a review.

J. Kopple, J. Coburn, M. Rubini, 1968, The American journal of clinical nutrition.

Unique effects of 24,25-dihydroxyvitamin D3 in uremic patients.

A. Brickman, J. Coburn, F. Llach, 1980, Contributions to nephrology.

Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status.

A. Norman, A. Brickman, K. Kurokawa, 1977, The Journal of clinical endocrinology and metabolism.

Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.

A. Norman, D. Sherrard, A. Brickman, 1980, Contributions to nephrology.

Interactions between treatment with 1,25(OH)2D3 and glucocorticoids in uremic patients after kidney transplantation.

J. Coburn, J. Sugihara, A. Siemsen, 1980, Contributions to nephrology.

Prospective evaluation of aluminum loading from formula in infants with uremia.

W. Goodman, I. Salusky, J. Coburn, 1990, The Journal of pediatrics.

Homeostasis and action of parathyroid hormone in normal man and patients with mild renal failure.

S. Massry, F. Singer, K. Kurokawa, 1975, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Spurious hypocalcemia in patients undergoing maintenance hemodialysis.

S. Massry, J. Coburn, M. Rubini, 1969, American Journal of Clinical Pathology.

Normophosphatemic phosphate depletion in growing rat.

C. Kleeman, J. Coburn, N. Brautbar, 1979, The American journal of physiology.

Intestinal phosphate absorption in normal and uremic man: effects of 1,25(OH)2-vitamin D3 and 1alpha(OH)-vitamin D3.

A. Norman, A. Brickman, J. Coburn, 1977, Advances in experimental medicine and biology.

1,25-Dihydroxyvitamin D3 stimulates calcium and phosphate absorption by different mechanisms: contrasting requirements for sodium.

D. Corry, J. Coburn, D. B. Lee, 1984, Advances in experimental medicine and biology.

PLASMA KINETICS OF INTRAVENOUS CALCITRIOL IN NORMAL AND DIALYSED SUBJECTS AND ACUTE EFFECT ON SERUM nPTH LEVELS.

Keith C. Norris, G. Segre, I. Salusky, 1988 .

METABOLIC BONE DISEASE IN TOTAL PARENTERAL NUTRITION

J. Coburn, M. Ament, G. Klein, 1981, The Lancet.